Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.3500
0.00 (0.00%)
Oct 30, 2026, 3:57 PM EDT
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 26.53 million as of October 30, 2026. It is the 37,164th most valuable company in the world and the 1,174th biggest in Canada. Its market cap has decreased by 39.41% in one year.
Market Cap
26.53M
Enterprise Value
26.36M
Revenue
n/a
Global Rank
Country Rank
#1,174 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 26.53M, a decrease of -70.22%. That is a compound annual growth rate of -19.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 26.53M | -35.78% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 40.41M |
| Sernova Biotherapeutics | 39.65M |
| BriaCell Therapeutics | 36.97M |
| MedMira | 35.09M |
| Sona Nanotech | 34.38M |
| ME Therapeutics Holdings | 33.43M |
| Resverlogix | 25.82M |
| Telescope Innovations | 24.65M |